FDA recall D-0150-2017

Product

LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620, NDC 60793-860-01

Reason for recall

Superpotent

Distribution

Nationwide

Key facts

Status

Terminated

Initiation date

2016-11-07

Report date

2016-11-30

Termination date

2020-05-01

Voluntary/Mandated

Voluntary: Firm initiated

Location

New York, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0150-2017